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  55 cases with chrGnic prostatitis were given anti－inflamrnatory agents， Esberiven， wit．h or without
Co－trirnoxazole daily for more than 8 weeks． The effectiveness was evaluated by improvements of
subjective symptoms and objective’findings including transrectal ultrasonotomography and urodynamic
study．
  ’1’he overall therapeutic effects of Esberiven alone were shown in 75．00／o of 16 cases and those
of Esberiven with Co－trimoxazole were shewn in 87．20／． of 39 cases． lt is suggested that Esberiven
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       Fig． 1． lmprovements of subjective symptoms．


























WBC counts in VB3
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Fig． 3． Evaluation by transrectal ultrasonotomogram．











1， T．M． 31y．o， E＄berlven for 6wks
．





III ． S．N． 42y．o． Esberiven with co－trimoxazole for 32wks
Fig． 4． The effect of Esberiven c／s Co－trimoxazole on transrectal ultrasonotomogram．
     Prostate is shown to be decreased in size． Changes of A－P diameter， lateral
    diameter and S－1 diameter in each case are 20×28×37 （mm） to 15×26×36
    （case 1）， 26×36×45 to 23×25×41 （case II） and ‘ro×32×44 to 30×28 x 46































1． M．N． 45y，o． Esberiven for I Owks．
〈塑解離
II． M．K， 36y．o， Esberiven with Co－trimoxazole for I O wks．
     



















m、K」． 67y．o． Esberiven with Co－trimoxazole for日wks．
／堕・バ
Fig． 5．Thc effect of Esberiven小Co－trimoxazole
on urofiowmetry．
































1．0 2．0 3．0 4．D 5．0 ．6．0 7．0（cm）
Fi・ 6． The effect of Esberiven on UPP．
    Changes of FPL， PPL and Max P are 5．6 cm to 4．9
   cm， 4．4 cm to 3．4 cm and 80 mmHg to 135 mmHg．
考 察
 慢性前立腺炎に対する薬効を評価する際，まず問題
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      resolved improved unchanged resolved improved unchanged
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Table 1． Effectiveness of esberiven．
Esberiven Esberiven  with
Co－trimoxazole
lmprovement of tenderness （O／e）







1mprovement of dysuria （e／e）
Average size decrease
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